According to their results, HPV16E6/18E6 and EGFR expression in NSCLC correlates with a greater survival rate in older lung adenocarcinoma patients without brain metastasis, with a smoking history, and with wild-type EGFR status. This evidence concerns the gene EGFR and non-small cell lung carcinoma.